AWM Investment Company Inc. lessened its holdings in shares of OncoCyte Co. (NASDAQ:OCX - Free Repor...
New price of $2,753 for the GraftAssureCore™ assay increases total addressable market size and margi...
Needham & Company LLC reiterated a "buy" rating and issued a $4.25 price objective on shares of Onco...
OncoCyte (NASDAQ:OCX - Get Free Report) posted its quarterly earnings results on Monday. The company...